HEALTHIER CHINA THROUGH INNOVATION

Under the China Association of Enterprises with Foreign Investment (CAEFI), the R&D-based Pharmaceutical Association Committee (RDPAC) is a non-profit organization made up of 42 member companies with pharmaceutical R&D capability.


Focus on Global Simultaneous Development and Talent Development

January 05, 2021
On December 18, 2020, the annual meeting of RDPAC R&D Committee was grandly held on the Roche Pharma Shanghai campus.

Innovation and Collaboration for Healthy China- RDPAC and its Member Companies Made a Wonderful Appearance at the CIIE

November 18, 2020
The “Innovation and Collaboration for Healthy China” conference given by RDPAC was solemnly held in the Medical Devices and Medical Care exhibition area of the China International Import Expo.

22 Pharmaceutical MNC Leaders' Messages to the Two Sessions

June 03, 2020
Two sessions were finally held after the outbreak, at this special historical moment, the China leader of RDPAC 22 member companies have shared their views

PUBLICATIONS

DEEPENING THE DRUG INNOVATION ECOSYSTEM REFORM – A PLAN TO DESIGN AND BUILD CHINA’S CLINICAL RESEARCH SYSTEM

Health is the common aspiration of all mankind, and a healthy China constitutes an integral part of the “China Dream”.